INDOLE DERIVATIVES HAVING COMBINED 5HT1A, 5HT1B AND 5HT1D RECEPTOR ANTAGONIST ACTIVITY - Patent 0975593

(19)

(11)

EP 0 975 593 A1

(12)

(43)	Date of publication:
	02.02.2000 Bulletin 2000/05

(21)	Application number: 98921462.2

(22)	Date of filing: 14.04.1998

(51)	International Patent Classification (IPC)⁷: C07D 209/08, C07D 401/12, C07D 403/12, C07D 417/12, C07D 413/12, A61K 31/40

(86)	International application number:
	PCT/EP9802/262

(87)	International publication number:
	WO 9850/358 (12.11.1998 Gazette 1998/45)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	SI

(30)

Priority:

18.04.1997 GB 9707829
29.01.1998 GB 9801882

(71)	Applicant: SMITHKLINE BEECHAM PLC
	Brentford,Middlesex TW8 9EP (GB)

(72)	Inventors:
	GASTER, Laramie, MarySmithKline Beecham Third AvenueHarlow, Essex CM19 5AW (GB) RAMI, Harshad, KantilalSmithKline Beecham Third AvenueHarlowEssex CM19 5AW (GB) WYMAN, Paul, AdrianSmithKline Beecham Third AvenueHarlowEssex CM19 5AW (GB)

(74)	Representative: Waters, David Martin, Dr.
	Smithkline Beecham plcCorporate Intellectual Property,Two New Horizons Court Brentford, Middlesex TW8 9EP Brentford, Middlesex TW8 9EP (GB)

(54)	INDOLE DERIVATIVES HAVING COMBINED 5HT1A, 5HT1B AND 5HT1D RECEPTOR ANTAGONIST ACTIVITY